These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6072020)

  • 1. Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants.
    Edson JR; Krivit W; White JG
    J Lab Clin Med; 1967 Sep; 70(3):463-70. PubMed ID: 6072020
    [No Abstract]   [Full Text] [Related]  

  • 2. The kaolin partial thromboplastin time as a screening test for coagulation disorders.
    Lurie A; Smith S
    S Afr Med J; 1968 May; 42(18):438-44. PubMed ID: 5655371
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrotic syndrome. A hypercoagulable state.
    Kendall AG; Lohmann RC; Dossetor JB
    Arch Intern Med; 1971 Jun; 127(6):1021-7. PubMed ID: 5578557
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clotting time and kaolin clotting time].
    Amagai H; Murakami M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():581-3. PubMed ID: 15658394
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
    Hjorth B; Kjaersgaard E
    Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fletcher factor deficiency (Report of a new case).
    Colla G; Carrea M; Sbaffi A
    Ric Clin Lab; 1983; 13(4):443-8. PubMed ID: 6558774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR
    Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin utilization in congenital coagulation deficiency states.
    Owen CA; Thompson JH
    Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
    [No Abstract]   [Full Text] [Related]  

  • 10. Simple screening tests for the diagnosis of isolated clotting factor defects. With special reference to 'contact factor' defects.
    Ingram GI; Knights SF; Arocha-Piñango CL; Shepperd JP; Pérez-Requejo JL; Mills DK
    J Clin Pathol; 1975 Jul; 28(7):524-30. PubMed ID: 1080159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of platelet factor-3 by the kaolin clotting time and thromboplastin generation time].
    Oki H; Takashima A
    Rinsho Byori; 1973 Jul; 21(7):621-6. PubMed ID: 4738067
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticonvulsivant-induced depression of clotting factors in children.
    Solomon GE; Hilgartner MW; Kutt H
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):277-84. PubMed ID: 616536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin time sensitivity and specificity to mild clotting factor deficiencies of the extrinsic pathway: evaluation of eight commercial thromboplastins.
    Massignon D; Moulsma M; Bondon P; Debize G; Abidi H; Buttin T; Bon C; Pillonchery G; Coeur P
    Thromb Haemost; 1996 Apr; 75(4):590-4. PubMed ID: 8743184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolated extension of cephalin-kaolin time (excluding hemophilia)].
    Parquet-Gernez A; Mazurier C; Goudemand M
    Lille Med; 1979 Oct; 24(8):607-12. PubMed ID: 537461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].
    Mingers AM; Mietens C; Ströder J
    Thromb Diath Haemorrh; 1971 Jun; 25(2):316-31. PubMed ID: 5568051
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemostatic defect due to acquired circulating inhibitors against lipid procoagulant and factor VIII.
    Pechet L; Snyder LM; Chesney C; Colman RW
    Thromb Diath Haemorrh; 1974 Sep; 32(1):90-104. PubMed ID: 4548947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Partial thromboplastin time activated with kaolin (PTTTK), a sensitive test of total plasmatic coagulability].
    Poppa C; Enache F; Cernat M
    Stud Cercet Med Interna; 1972; 13(5):489-93. PubMed ID: 4645066
    [No Abstract]   [Full Text] [Related]  

  • 18. The partial thromboplastin time test: distinction between inhibitor and clotting-factor deficiency.
    Knights SF; Wadey CA
    Med Lab Technol; 1973 Jan; 30(1):43-7. PubMed ID: 4718028
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of long-term plasmapheresis on blood coagulation.
    Grgicević D
    Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired coagulopathy owing to parenteral cefamandole: renal failure as a predisposing factor.
    Chang JC
    Ann Clin Lab Sci; 1983; 13(5):418-24. PubMed ID: 6638932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.